Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Definitive Healthcare Corp (DH – Research Report), Anavex Life Sciences (AVXL – Research Report) and Liquidia Technologies (LQDA – Research Report).
Definitive Healthcare Corp (DH)
Bank of America Securities analyst Allen Lutz reiterated a Hold rating on Definitive Healthcare Corp yesterday and set a price target of $11.00. The company’s shares closed last Wednesday at $10.73, close to its 52-week low of $8.71.
According to TipRanks.com, Lutz is a 2-star analyst with an average return of
Currently, the analyst consensus on Definitive Healthcare Corp is a Moderate Buy with an average price target of $13.38.
See the top stocks recommended by analysts >>
Anavex Life Sciences (AVXL)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Anavex Life Sciences, with a price target of $54.00. The company’s shares closed last Wednesday at $7.98, close to its 52-week low of $7.44.
According to TipRanks.com, Selvaraju is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Anavex Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $45.00, representing a 456.2% upside. In a report issued on June 15, Berenberg Bank also reiterated a Buy rating on the stock with a $40.00 price target.
Liquidia Technologies (LQDA)
Bank of America Securities analyst Greg Harrison maintained a Buy rating on Liquidia Technologies yesterday and set a price target of $13.00. The company’s shares closed last Wednesday at $9.90, close to its 52-week high of $9.95.
According to TipRanks.com, Harrison is a 3-star analyst with an average return of
Liquidia Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $14.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DH:
- Definitive Healthcare expands the Atlas Dataset
- Definitive Healthcare to Present at the Stifel 2023 Cross Sector Insight Conference and the 43rd Annual William Blair Growth Stock Conference
- Definitive Healthcare publishes 2022 Sustainability Report
- Definitive Healthcare to Present at the 51st Annual J.P. Morgan Global Technology, Media and Communications Conference
